We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Soil Bacteria As a Rich Source of Enediyne Antibiotics and Anti-Cancer Compounds

By LabMedica International staff writers
Posted on 04 Jan 2017
Following the screening of more than 3,400 different actinomycete (soil bacteria) isolates, researchers have isolated several powerful new antibiotics and potential anti-cancer compounds.

Investigators at The Scripps Research Institute (Jupiter, FL, USA) surveyed the genomes of some 3,400 actinomycetes, identifying 81 strains that harbored genes encoding the enediyne polyketide synthase family of enzymes.

The enediyne polyketides are secondary metabolites isolated from a variety of Actinomycetes. More...
All members share very potent anti-cancer and antibiotic activity. The biosynthesis of these compounds is of interest because of the numerous structural features that are unique to the enediyne family. The gene cluster for five enediynes has now been cloned and sequenced, providing the foundation to understand natures’ means to biosynthesize such complex, exotic molecules.

A macromolecular antibiotic C-1027 had been obtained previously from the broth filtrate of Streptomyces globisporus by precipitation with ammonium sulfate, DEAE-cellulose column chromatography, and gel filtration chromatography on a Sephadex G-75 column.

In the current study, the investigators identified new C-1027 producers, with a significantly higher C-1027 titer than the original producer, and discovered a new family of enediyne natural products, the tiancimycins (TNMs), that exhibited potent cytotoxicity against a broad spectrum of cancer cell lines.

"The enediynes represent one of the most fascinating families of natural products for their extraordinary biological activities," said senior author Dr. Ben Shen, professor of chemistry at The Scripps Research Institute. "By surveying 3,400 strains from the The Scripps Research Institute collection, we were able to identify 81 strains that harbor genes encoding enediynes. With what we know, we can predict novel structural insights that can be exploited to radically accelerate enediyne-based drug discovery and development."

Related Links:
The Scripps Research Institute


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.